Oxytocics

Madhusudan Upadya; Mahesh Nayak

doi:10.1029/WFSA-D-18-00033

Oxytocics

Madhusudan Upadya, Mahesh Nayak

Department of Anaesthesiology, Kasturba Medical College, Mangalore

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Abstract

Postpartum hemorrhage remains the leading cause of maternal mortality and morbidity. Oxytocic drugs are the main stay in prevention as well as treatment. Oxytocin remains the drug of choice. The use of 5 IU bolus dose has been questioned in recent times. Current evidence suggests infusion to be a preferred choice than bolus dosage. Carbetocin is a newer alternative to oxytocin. Second line drugs include ergot alkaloids (Methyl ergometrine) and prostaglandins (carboprost and misoprostol) which are used as adjuvants to oxytocin in hemorrhage.

Original language	English
Pages (from-to)	78-80
Number of pages	3
Journal	Update in Anaesthesia
Volume	34
DOIs	https://doi.org/10.1029/WFSA-D-18-00033
Publication status	Published - 01-01-2019

All Science Journal Classification (ASJC) codes

Anesthesiology and Pain Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1029/WFSA-D-18-00033

Cite this

@article{b72e0011d84c464cb02fd2642d010445,

title = "Oxytocics",

abstract = "Postpartum hemorrhage remains the leading cause of maternal mortality and morbidity. Oxytocic drugs are the main stay in prevention as well as treatment. Oxytocin remains the drug of choice. The use of 5 IU bolus dose has been questioned in recent times. Current evidence suggests infusion to be a preferred choice than bolus dosage. Carbetocin is a newer alternative to oxytocin. Second line drugs include ergot alkaloids (Methyl ergometrine) and prostaglandins (carboprost and misoprostol) which are used as adjuvants to oxytocin in hemorrhage.",

author = "Madhusudan Upadya and Mahesh Nayak",

year = "2019",

month = jan,

day = "1",

doi = "10.1029/WFSA-D-18-00033",

language = "English",

volume = "34",

pages = "78--80",

journal = "Update in Anaesthesia",

issn = "1353-4882",

publisher = "Roayal Devon and Exeter Healthcare NHS Trust",

}

TY - JOUR

T1 - Oxytocics

AU - Upadya, Madhusudan

AU - Nayak, Mahesh

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Postpartum hemorrhage remains the leading cause of maternal mortality and morbidity. Oxytocic drugs are the main stay in prevention as well as treatment. Oxytocin remains the drug of choice. The use of 5 IU bolus dose has been questioned in recent times. Current evidence suggests infusion to be a preferred choice than bolus dosage. Carbetocin is a newer alternative to oxytocin. Second line drugs include ergot alkaloids (Methyl ergometrine) and prostaglandins (carboprost and misoprostol) which are used as adjuvants to oxytocin in hemorrhage.

AB - Postpartum hemorrhage remains the leading cause of maternal mortality and morbidity. Oxytocic drugs are the main stay in prevention as well as treatment. Oxytocin remains the drug of choice. The use of 5 IU bolus dose has been questioned in recent times. Current evidence suggests infusion to be a preferred choice than bolus dosage. Carbetocin is a newer alternative to oxytocin. Second line drugs include ergot alkaloids (Methyl ergometrine) and prostaglandins (carboprost and misoprostol) which are used as adjuvants to oxytocin in hemorrhage.

UR - http://www.scopus.com/inward/record.url?scp=85075613594&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85075613594&partnerID=8YFLogxK

U2 - 10.1029/WFSA-D-18-00033

DO - 10.1029/WFSA-D-18-00033

M3 - Article

AN - SCOPUS:85075613594

SN - 1353-4882

VL - 34

SP - 78

EP - 80

JO - Update in Anaesthesia

JF - Update in Anaesthesia

ER -

Oxytocics

Abstract

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this